BridgeBio Pharma, Inc. (BBIO) Revenue by Year
BridgeBio Pharma, Inc. generated $502.1M in revenue in fiscal year 2025. This represents an increase of 126.3% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $713.1M in revenue. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters BridgeBio Pharma, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
BBIO Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
BBIO Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More BridgeBio Pharma, Inc. financials
Frequently Asked Questions
What was BridgeBio Pharma, Inc.'s revenue in fiscal year 2025?
BridgeBio Pharma, Inc. generated $502.1M in revenue in fiscal year 2025.
How fast is BridgeBio Pharma, Inc.'s revenue growing?
BridgeBio Pharma, Inc. (BBIO) revenue rose by 126.3% year over year, from $221.9M to $502.1M in fiscal year 2025.
What is BridgeBio Pharma, Inc.'s revenue over the last twelve months?
BridgeBio Pharma, Inc. (BBIO) reported $713.1M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
What was BridgeBio Pharma, Inc.'s revenue in the most recent quarter?
BridgeBio Pharma, Inc. (BBIO) reported $243.7M in revenue in Q2 2026. This represents an increase of 120.4% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what BridgeBio Pharma, Inc. (BBIO) reported on that line in every period on record.